アデノシンA2a受容体が欠けているマウスにおける攻撃性,低アルゲシア,高血圧
C Ledent1, J M Vaugeois, S N Schiffmann
1IRIBHN, Université Libre de Bruxelles, Campus Erasme, Belgium.
Nature
|August 14, 1997
まとめ
アデノシンA2a受容体 (A2aR) が欠けているマウスは,探検の減少,不安と攻撃性の増加を含む行動の変化を示した. これは,A2aRがこれらの反応を調節する上で重要な役割を果たしていることを示唆しています.
科学分野:
- 神経科学は神経科学である.
- 薬理学 薬理学とは
- 生理学 生理学とは
背景:
- アデノシンは,ストレス中に細胞の保護に関与する重要な細胞外媒介体です.
- アデノシンは,A2a受容体 (A2aR) を含む4つの受容体サブタイプを通じてその効果を発揮します.
- A2aRは基礎性腺,血管系,血小板に多く存在し,カフェインの主な標的である.
研究 の 目的:
- アデノシンA2a受容体 (A2aR) の生理学的および行動的役割を調査する.
主な方法:
- A2aR-ノックアウト (A2aR-/-) マウスの生成と分析.
- 探索活動,不安のような行動,攻撃性,痛み反応,心臓血管のパラメータ,血小板の集積の評価.
主要な成果:
- A2aR-/-マウスは探検活動が低下し,不安や攻撃性が高まった.
- これらのマウスは,痛み刺激に対して鈍感な反応を示し,血圧,心拍数,血小板の集積が増加した.
- A2a受容体アゴニストCGS 21680の生物学的活動は,ノックアウト動物で廃止されました.
結論:
- アデノシンA2a受容体は,探検的行動,不安,攻撃性,痛み知覚,心血管機能の調節に不可欠です.
- A2aRシグナル伝達の障害は,刺激に対する反応とカフェインの効果を大幅に変化させます.
関連する概念動画
01:27Adrenergic Receptors (Adrenoceptors): Classification
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
01:31Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...